YWYaohua Wang

Yaohua Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yaohua Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Checkmate or Checkpoint?

    by Yaohua Wang, Benjamin R. Griffin

    Was not provided for this article.

  • Open Access

    L‐VISP: LSTM Visualization for Interpretable Symptom Prediction in Patient Cohorts

    by C. Floricel, Y. Wang, A. Wentzel, C. D. Fuller, G. E. Marai, M. E. Papka, G. Canahuate

    Symptom modelling in head and neck cancer is challenged by the complexity of heterogeneous patient data, leading to an interest in deep learning approaches. Although Long Short‐Term Memory Networks (LSTMs) have shown great results in patient risk prediction, their low interpretability requires data modellers to collaborate with clinical experts to validate the results. We present L‐VISP, a human–machine solution that uses visual analytics for LSTM modelling in clinical research. L‐VISP uses custom visual encodings to make multiple LSTM variants interpretable, supporting a full range of analysis, from understanding model operations and evaluating performance to interpreting results in a clinical context. We evaluate L‐VISP with data modellers and a clinical oncologist and present the takeaways from this multidisciplinary collaboration.

  • Top Cited Papers
    Open Access

    Personalized Antibiogram: A Novel Multitask Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile With Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae

    by Michihiko Goto, Anindita Bandyopadhyay, Qianyi Shi, Yaohua Wang, Eli N Perencevich, David Hernandez, W Nick Street

    Background: Conventional hospital antibiograms summarize aggregated resistance rates, limiting their utility for individualized antimicrobial selection. Existing statistical and machine learning models predict each phenotype separately, ignoring correlations among resistance profiles. We developed novel multitask extreme gradient boosting (XGBoost) models utilizing structured data in electronic health records (EHRs) to predict resistance to 8 antimicrobial classes simultaneously and evaluated their performance within the Veterans Health Administration (VHA). Methods: We conducted a retrospective multicenter study of Escherichia coli and Klebsiella spp. isolates collected at 127 hospitals and >1400 clinics from January 2017 to September 2024. Data from January 2017 to September 2023 were used for model development, while data from October 2023 to September 2024 were used for simulated prospective testing. Model performances were compared to hospital antibiograms and single-target XGBoost models. Results: The training cohort included 536 252 E. coli and 246 898 Klebsiella spp. isolates; the test cohort included 75 138 and 38 015 isolates, respectively. On the test data, the multitask model achieved overall areas under the receiver operating characteristic curve (AUROCs) of 0.779 (E. coli) and 0.810 (Klebsiella spp.), with good to excellent per-class performance (AUROC range, 0.743–0.847). A multitask approach improved calibration and decreased false-negative rates for carbapenem resistance while predicting individualized resistance probabilities for all target antimicrobials simultaneously (“personalized antibiograms”). Conclusions: A multitask XGBoost framework can accurately predict individualized resistance profiles for common Gram-negative pathogens, outperforming conventional antibiograms and single-target models. Personalized antibiograms may enhance the selection of empiric therapy, including the detection of carbapenem resistance in low-endemicity settings.


  • Open Access

    Evaluating Dimensionality Reduction for Patient-Reported Outcome–Based Survival Modeling in Patients With Head and Neck Cancer

    by Eric Ababio Anyimadu, Yaohua Wang, Amy C. Moreno, Clifton David Fuller, Xinhua Zhang, G. Elisabeta Marai, Guadalupe M. Canahuate

    PURPOSE: This study aims to improve survival modeling in head and neck cancer (HNC) by integrating patient-reported outcomes (PROs) using dimensionality reduction techniques. PROs capture symptom severity across the treatment timeline and offer key insights for personalized care. However, their high dimensionality poses challenges such as overfitting and computational complexity. This work focuses on transforming and incorporating PRO data to enhance model performance in HNC. MATERIALS AND METHODS: We analyzed retrospective data of 923 patients with HNC treated at the University of Texas MD Anderson Cancer Center between 2010 and 2021. Baseline clinical data including demographic, treatment, and disease characteristics were used to build a reference survival model. PRO data, capturing symptom ratings, were integrated using dimensionality reduction techniques: principal component analysis (PCA), autoencoders (AEs), and patient clustering. These reduced representations, combined with clinical data, were input into Cox proportional hazards models to predict overall survival (OS) and progression-free survival (PFS). Model performance was assessed using the concordance index, time-dependent AUC, Brier score for calibration, and hazard ratios for predictor significance. RESULTS: Cox models incorporating PCA and AE outperformed the clinical-only reference model for both OS and PFS. The PCA-based model achieved the highest C-indices (0.74 for OS and 0.64 for PFS), followed by the AE model (0.73 and 0.63) and the clustering model (0.72 and 0.62). Time-dependent AUCs reinforced these results, with PCA showing the highest average AUC over 36 months. All models were well-calibrated, with low Brier scores. Key predictors included age, disease stage, and tumor subsite. CONCLUSION: Dimensionality reduction techniques improve survival prediction in patients with HNC by effectively incorporating PRO data, potentially providing greater insights into more personalized treatment strategies.


  • PRO-Based Stratification Improves Model Prediction for Toxicity and Survival of Head and Neck Cancer Patients

    by Eric A. Anyimadu, Yaohua Wang, Carla Floricel, Serageldin Kamel, Clifton David Fuller, Xinhua Zhang, G. Elisabeta Marai, Guadalupe M. Canahuate

    Patient-Reported Outcomes (PRO) consist of information provided directly by the patients about their health status including symptom ratings. PROs are commonly used in clinical practice to support clinical decisionmaking and have recently been incorporated into machine learning models to improve risk prediction. In this work, we aim to evaluate whether the inclusion of a patient stratification based on 12-month post-treatment predicted Patient Reported Outcomes improves risk prediction of radiationinduced toxicity and overall survival for head and neck cancer patients. A bidirectional long-short term memory (Bi-LSTM) recurrent neural network was used to model the longitudinal PRO data and to predict symptom ratings 12 months posttreatment. Patients were stratified using hierarchical clustering over the LSTM-predicted data. A logistic regression model was trained to predict Xerostomia at 12 months and a Cox regression model to predict overall survival. Results show that the inclusion of symptom burden clusters derived from the predicted Patient Reported Outcomes improves radiation-induced toxicity and overall survival prediction for head and neck cancer patients.


  • Open Access

    Evaluating Autoencoders for Dimensionality Reduction of MRI-derived Radiomics and Classification of Malignant Brain Tumors

    by Mikayla Biggs, Yaohua Wang, Neetu Soni, Sarv Priya, Girish Bathla, Guadalupe Canahuate

    Malignant brain tumors including parenchymal metastatic (MET) lesions, glioblastomas (GBM), and lymphomas (LYM) account for 29.7% of brain cancers. However, the characterization of these tumors from MRI imaging is difficult due to the similarity of their radiologically observed image features. Radiomics is the extraction of quantitative imaging features to characterize tumor intensity, shape, and texture. Applying machine learning over radiomic features could aid diagnostics by improving the classification of these common brain tumors. However, since the number of radiomic features is typically larger than the number of patients in the study, dimensionality reduction is needed to balance feature dimensionality and model complexity. Autoencoders are a form of unsupervised representation learning that can be used for dimensionality reduction. It is similar to PCA but uses a more complex and non-linear model to learn a compact latent space. In this work, we examine the effectiveness of autoencoders for dimensionality reduction on the radiomic feature space of multiparametric MRI images and the classification of malignant brain tumors: GBM, LYM, and MET. We further aim to address the class imbalances imposed by the rarity of lymphomas by examining different approaches to increase overall predictive performance through multiclass decomposition strategies.